Prediction of Human Oral Plasma Concentration-Time Profiles Using Preclinical Data

[1]  L. A. Fenu,et al.  Towards a Better Prediction of Peak Concentration, Volume of Distribution and Half-Life after Oral Drug Administration in Man, Using Allometry , 2011, Clinical pharmacokinetics.

[2]  W. Humphreys,et al.  Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds , 2008, Biopharmaceutics & drug disposition.

[3]  So H. Kim,et al.  Interspecies pharmacokinetic scaling of DA‐8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics , 2005, Biopharmaceutics & drug disposition.

[4]  Iftekhar Mahmood,et al.  Interspecies scaling of biliary excreted drugs: a comparison of several methods. , 2005, Journal of pharmaceutical sciences.

[5]  Yoshitaka Yano,et al.  Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles. , 2004, Journal of pharmaceutical sciences.

[6]  J. Duconge,et al.  Interspecies scaling of the monoclonal anti‐EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable? , 2004, Biopharmaceutics & drug disposition.

[7]  Y. Yano,et al.  Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state , 2003, The Journal of pharmacy and pharmacology.

[8]  B. Shin,et al.  Pharmacokinetic scaling of SJ‐8029, a novel anticancer agent possessing microtubule and topoisomerase inhibiting activities, by species‐invariant time methods , 2003, Biopharmaceutics & drug disposition.

[9]  Yoshitaka Yano,et al.  Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis. , 2002, Journal of pharmaceutical sciences.

[10]  I. Mahmood,et al.  Interspecies scaling of biliary excreted drugs. , 2002, Journal of pharmaceutical sciences.

[11]  B. Shin,et al.  Pharmacokinetic scaling of bisphenol A by species-invariant time methods , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  Xiaochun Lou,et al.  Allometric Pharmacokinetic Scaling: Towards the Prediction of Human Oral Pharmacokinetics , 2000, Pharmaceutical Research.

[13]  R. Yuan,et al.  A comparative study of allometric scaling with plasma concentrations predicted by species‐invariant time methods , 1999, Biopharmaceutics & drug disposition.

[14]  I Mahmood,et al.  Interspecies scaling of renally secreted drugs. , 1998, Life sciences.

[15]  So H. Kim,et al.  Interspecies pharmacokinetic scaling of a new carbapenem, DA‐1131, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics , 1998, Biopharmaceutics & drug disposition.

[16]  D J Rance,et al.  The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. , 1997, The Journal of pharmacology and experimental therapeutics.

[17]  R C Chou,et al.  Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. , 1997, Journal of pharmaceutical sciences.

[18]  J. Mordenti,et al.  Man versus beast: pharmacokinetic scaling in mammals. , 1986, Journal of pharmaceutical sciences.

[19]  H. Boxenbaum,et al.  Interspecies pharmacokinetic scaling and the Dedrick plots. , 1983, The American journal of physiology.

[20]  Harold Boxenbaum,et al.  Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics , 1982, Journal of Pharmacokinetics and Biopharmaceutics.

[21]  K. Bischoff,et al.  Interspecies correlation of plasma concentration history of methotrexate (NSC-740). , 1970, Cancer chemotherapy reports.

[22]  Dennis A Smith,et al.  Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research? , 2009, Current opinion in drug discovery & development.

[23]  L. A. Fenu,et al.  Predicting Oral Clearance in Humans , 2008, Clinical pharmacokinetics.

[24]  T. Lavé,et al.  A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics , 2006, Clinical pharmacokinetics.

[25]  I. Mahmood.  Can Absolute Oral Bioavailability in Humans be Predicted from Animals? A Comparison of Allometry and Different Indirect Methods , 2000, Drug metabolism and drug interactions.

[26]  J. Balian,et al.  Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[27]  H Boxenbaum,et al.  Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. , 1984, Drug metabolism reviews.